These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22736508)

  • 1. Scalable syntheses of both enantiomers of DNJNAc and DGJNAc from glucuronolactone: the effect of N-alkylation on hexosaminidase inhibition.
    Glawar AF; Best D; Ayers BJ; Miyauchi S; Nakagawa S; Aguilar-Moncayo M; García Fernández JM; Ortiz Mellet C; Crabtree EV; Butters TD; Wilson FX; Kato A; Fleet GW
    Chemistry; 2012 Jul; 18(30):9341-59. PubMed ID: 22736508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective synthesis of 2-acetamido-1,2-dideoxynojirimycin (DNJNAc) and ureido-DNJNAc derivatives as new hexosaminidase inhibitors.
    de la Fuente A; Mena-Barragán T; Farrar-Tobar RA; Verdaguer X; García Fernández JM; Ortiz Mellet C; Riera A
    Org Biomol Chem; 2015 Jun; 13(23):6500-10. PubMed ID: 25975710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective synthesis of 2-acetamido-1,2-dideoxyallonojirimycin (DAJNAc), a new potent hexosaminidase inhibitor.
    de la Fuente A; Martin R; Mena-Barragán T; Verdaguer X; García Fernández JM; Ortiz Mellet C; Riera A
    Org Lett; 2013 Jul; 15(14):3638-41. PubMed ID: 23802126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient stereoselective synthesis of 2-acetamido-1,2-dideoxyallonojirimycin (DAJNAc) and sp(2)-iminosugar conjugates: Novel hexosaminidase inhibitors with discrimination capabilities between the mature and precursor forms of the enzyme.
    de la Fuente A; Rísquez-Cuadro R; Verdaguer X; García Fernández JM; Nanba E; Higaki K; Ortiz Mellet C; Riera A
    Eur J Med Chem; 2016 Oct; 121():926-938. PubMed ID: 26564401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating thin film microfluidics in developing a concise synthesis of DGJNAc: A potent inhibitor of α-N-acetylgalctosaminidases.
    Wills SS; Raston CL; Stubbs KA
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3748-3751. PubMed ID: 30366618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosidase inhibition by all 10 stereoisomeric 2,5-dideoxy-2,5-iminohexitols prepared from the enantiomers of glucuronolactone.
    Ayers BJ; Ngo N; Jenkinson SF; Martínez RF; Shimada Y; Adachi I; Weymouth-Wilson AC; Kato A; Fleet GW
    J Org Chem; 2012 Sep; 77(18):7777-92. PubMed ID: 22928735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A stereocontrolled synthesis of 3-acetamido-1,3,5-trideoxy- and 1,3,5,6-tetradeoxy-1,5-imino-D-glucitol.
    Simák O; Stanek J; Moravcová J
    Carbohydr Res; 2009 May; 344(8):966-71. PubMed ID: 19375073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases.
    Asano N; Nishida M; Kato A; Kizu H; Matsui K; Shimada Y; Itoh T; Baba M; Watson AA; Nash RJ; Lilley PM; Watkin DJ; Fleet GW
    J Med Chem; 1998 Jul; 41(14):2565-71. PubMed ID: 9651160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological properties of D- and L-1-deoxyazasugars.
    Kato A; Kato N; Kano E; Adachi I; Ikeda K; Yu L; Okamoto T; Banba Y; Ouchi H; Takahata H; Asano N
    J Med Chem; 2005 Mar; 48(6):2036-44. PubMed ID: 15771446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthesis of L-Iminofuranoses and Their Biological Evaluations].
    Natori Y
    Yakugaku Zasshi; 2021; 141(1):15-24. PubMed ID: 33390442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bicyclic (galacto)nojirimycin analogues as glycosidase inhibitors: effect of structural modifications in their pharmacological chaperone potential towards β-glucocerebrosidase.
    Aguilar-Moncayo M; García-Moreno MI; Trapero A; Egido-Gabás M; Llebaria A; Fernández JM; Mellet CO
    Org Biomol Chem; 2011 May; 9(10):3698-713. PubMed ID: 21451818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of C-5a-substituted derivatives of 4-epi-isofagomine: notable β-galactosidase inhibitors and activity promotors of GM1-gangliosidosis related human lysosomal β-galactosidase mutant R201C.
    Thonhofer M; Weber P; Gonzalez Santana A; Tysoe C; Fischer R; Pabst BM; Paschke E; Schalli M; Stütz AE; Tschernutter M; Windischhofer W; Withers SG
    Carbohydr Res; 2016 Jun; 429():71-80. PubMed ID: 27063389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of glycosidase inhibitors: gem-difluoromethylenated nojirimycin analogues.
    Wang RW; Qiu XL; Bols M; Ortega-Caballero F; Qing FL
    J Med Chem; 2006 May; 49(10):2989-97. PubMed ID: 16686540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach to the 1-deoxynojirimycin system: synthesis from sucrose of 2-acetamido-1, 2-dideoxynojirimycin, as well as some 2-N-modified derivatives.
    Gradnig G; Legler G; Stütz AE
    Carbohydr Res; 1996 Jun; 287(1):49-57. PubMed ID: 8765059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of 1,6-di-deoxy-d-galacto and 1,6-di-deoxy-l-altro nojirimycin derivatives by aminocyclization of a 1,5-dicarbonyl derivative.
    Cuffaro D; Landi M; D'Andrea F; Guazzelli L
    Carbohydr Res; 2019 Aug; 482():107744. PubMed ID: 31306898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of alkylated deoxynojirimycin and 1,5-dideoxy-1,5-iminoxylitol analogues: polar side-chain modification, sulfonium and selenonium heteroatom variants, conformational analysis, and evaluation as glycosidase inhibitors.
    Szczepina MG; Johnston BD; Yuan Y; Svensson B; Pinto BM
    J Am Chem Soc; 2004 Oct; 126(39):12458-69. PubMed ID: 15453780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N- and C-alkylation of seven-membered iminosugars generates potent glucocerebrosidase inhibitors and F508del-CFTR correctors.
    Désiré J; Mondon M; Fontelle N; Nakagawa S; Hirokami Y; Adachi I; Iwaki R; Fleet GW; Alonzi DS; Twigg G; Butters TD; Bertrand J; Cendret V; Becq F; Norez C; Marrot J; Kato A; Blériot Y
    Org Biomol Chem; 2014 Nov; 12(44):8977-96. PubMed ID: 25277226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convergent approach toward the synthesis of the stereoisomers of C-6 homologues of 1-deoxynojirimycin and their analogues: evaluation as specific glycosidase inhibitors.
    Pandey G; Dumbre SG; Khan MI; Shabab M
    J Org Chem; 2006 Oct; 71(22):8481-8. PubMed ID: 17064023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphiphilic 1-deoxynojirimycin derivatives through click strategies for chemical chaperoning in N370S Gaucher cells.
    Diot JD; Garcia Moreno I; Twigg G; Ortiz Mellet C; Haupt K; Butters TD; Kovensky J; Gouin SG
    J Org Chem; 2011 Oct; 76(19):7757-68. PubMed ID: 21830816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An expeditious one-pot synthesis of 1,6-dideoxy-N-alkylated nojirimycin derivatives and their inhibitory effects on the secretion of IFN-gamma and IL-4.
    Zhou J; Zhang Y; Zhou X; Zhou J; Zhang LH; Ye XS; Zhang XL
    Bioorg Med Chem; 2008 Feb; 16(4):1605-12. PubMed ID: 18060793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.